OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
37
Results
Show all
Save search
Copy query
Show results for
Unknown
(37)
Publication Date
Release Date
2019
(6)
2023
(5)
2022
(3)
2013
(3)
2024
(2)
2021
(2)
2020
(2)
2018
(2)
2017
(2)
2016
(2)
2015
(2)
2014
(2)
2026
(1)
2010
(1)
2009
(1)
2000
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.
Not available
S-EPMC4026579
|
biostudies-literature
Cite
Safety and tolerability of quizartinib, a FLT3 inhibitor, in advanced solid tumors: a phase 1 dose-escalation trial.
Not available
S-EPMC6080548
|
biostudies-literature
Cite
Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial.
Not available
S-EPMC5783302
|
biostudies-literature
Cite
Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.
Not available
S-EPMC6771856
|
biostudies-literature
Cite
Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.
Not available
S-EPMC5070559
|
biostudies-literature
Cite
Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin.
Not available
S-EPMC6916570
|
biostudies-literature
Cite
Why tyrosine kinase inhibitor resistance is common in advanced gastrointestinal stromal tumors.
Not available
S-EPMC3892920
|
biostudies-literature
Cite
Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma.
Not available
S-EPMC4393337
|
biostudies-literature
Cite
KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors.
Not available
S-EPMC1876850
|
biostudies-literature
Cite
Concurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GIST.
Not available
S-EPMC9681737
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
